HAE FY 2019 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2019 Earnings

Reported May 22, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2019	Prior Q	FY 2018	QoQ Change	YoY Change
Revenue	$968M	—	$904M	—	7.0%
Op. Income	$84M	—	$56M	—	48.8%
Gross Margin	43.2%	—	45.6%	—	-2.4pp
Net Margin	5.7%	—	5.0%	—	0.6pp
EPS (Diluted)	$1.04	—	$0.85	—	22.4%
Free Cash Flow	$40M	—	$146M	—	-72.3%

Revenue Flow

Item	Amount
REVENUE	$968M
Cost of Revenue	$550M
GROSS PROFIT	$418M
R&D Expenses	$36M
Selling & Marketing	$5M
General & Administrative	$294M
SG&A Expenses	$298M
Other Expenses	$0
Operating Expenses	$334M
Cost & Expenses	$884M
OPERATING INCOME	$84M
Interest Income	$0
Interest Expense	$10M
Other Income/Expenses	-$10M
INCOME BEFORE TAX	$74M
Income Tax Expense	$19M
Net Income from Continuing Ops	$55M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$55M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$55M
D&A	$109M
EBIT	$84M
EBITDA	$193M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$968M
Cost of Revenue	$550M
GROSS PROFIT	$418M
R&D Expenses	$36M
Selling & Marketing	$5M
General & Administrative	$294M
SG&A Expenses	$298M
Other Expenses	$0
Operating Expenses	$334M
Cost & Expenses	$884M
OPERATING INCOME	$84M
Interest Income	$0
Interest Expense	$10M
Other Income/Expenses	-$10M
INCOME BEFORE TAX	$74M
Income Tax Expense	$19M
Net Income from Continuing Ops	$55M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$55M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$55M
D&A	$109M
EBIT	$84M
EBITDA	$193M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$55M
Depreciation & Amortization	$109M
Stock-Based Compensation	$17M
Deferred Income Tax	$13M
Other Non-Cash Items	$27M
Change in Working Capital	-$63M
OPERATING CASH FLOW	$159M
Capital Expenditure	-$119M
Acquisitions (Net)	$3M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$3M
NET CASH FROM INVESTING	-$116M
Net Debt Issuance	$96M
Common Stock Repurchased	-$160M
Common Dividends Paid	$0
Other Financing Activities	$13M
NET CASH FROM FINANCING	-$51M
FREE CASH FLOW	$40M
Net Change in Cash	-$11M

Balance Sheet

Item	Amount
Cash & Equivalents	$169M
Short-Term Investments	$0
Net Receivables	$185M
Inventory	$194M
Other Current Assets	$27M
TOTAL CURRENT ASSETS	$576M
PP&E (Net)	$344M
Goodwill	$211M
Intangible Assets	$128M
Long-Term Investments	-$4M
Tax Assets	$4M
Other Non-Current Assets	$16M
TOTAL NON-CURRENT ASSETS	$699M
TOTAL ASSETS	$1.3B
Account Payables	$63M
Short-Term Debt	$28M
Deferred Revenue	$27M
Other Current Liabilities	$56M
TOTAL CURRENT LIABILITIES	$236M
Long-Term Debt	$322M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$23M
Other Non-Current Liabilities	$26M
TOTAL NON-CURRENT LIABILITIES	$371M
TOTAL LIABILITIES	$607M
Common Stock	$510.0K
Additional Paid-In Capital	$536M
Retained Earnings	$161M
Treasury Stock	$0
Accum. Other Comp. Income	-$30M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$668M
Minority Interest	$0
TOTAL EQUITY	$668M
TOTAL LIABILITIES & EQUITY	$1.3B
Total Debt	$350M
Net Debt	$181M